Who
Kostas D. Odysseas
Director
Company insider
Files Form 4 as: Director, Amarin Corporation; Director, Armata Pharmaceuticals; Director, Innoviva; Director, Savara.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 2 Feb 2010
- Last trade
- 18 Apr 2026
- Last filed
- 21 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —838 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $6,037403 at $14.98 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —838 at $0.00 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —838 at $0.00 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —838 | filing |
| 18 Apr 2026filed 21 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $6,037403 at $14.98 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,640 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,640 at $0.00 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —838 at $0.00 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —838 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $3,981437 at $9.11 | filing |
| 5 Feb 2025filed 7 Feb 2025 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,343 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —13,923 at $0.00 | filing |
| 18 Apr 2024filed 19 Apr 2024 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —179,795 at $0.00 | filing |
| 18 Apr 2024filed 19 Apr 2024 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,287 at $0.00 | filing |
| 14 Mar 2024filed 18 Mar 2024 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,666 at $0.00 | filing |
| 14 Mar 2024filed 18 Mar 2024 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,343 at $0.00 | filing |
| 21 Dec 2023filed 26 Dec 2023 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,461 at $0.00 | filing |
| 21 Jul 2023filed 21 Jul 2023 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —258,598 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.